ORTHOPEDIC BIOMATERIAL MARKET ANALYSIS

Orthopedic Biomaterial Market, By Material Type (Glass-ceramic & Bioactive Glasses, Calcium Phosphate Cements, Polymer, Metals, Composites), By Application (Joint Replacement, Spine Implants, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fixation, Others), By End User (Hospitals, Orthopedic Clinics, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Oct 2023
Code : CMI4474
Pages :188
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Orthopedic Biomaterial Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global orthopedic biomaterial market over the forecast period. North America is estimated to hold 44.6% of the market share in 2023. The North America region is expected to dominate the global orthopedic biomaterial market over the forecast period. The large presence of major medical device manufacturers in the U.S. is a key factor driving growth in this region. The U.S. is home to large multinational corporations like Johnson & Johnson, Stryker, Zimmer Biomet, and Medtronic, all medical technology companies which together account for over 80% of the orthopedic biomaterial market in the region. Moreover, increasing acquisitions between market players are expected to drive the market growth in the region. For instance, in September 2023, Restor3d, the U.S.-based manufacturer of 3D-printed orthopedic implants, announced the completion of its previously announced acquisition of restor3d, a company that manufactures customized knee and hip replacements. Restor3d provides patient-specific, patient-matched, and auxiliary goods. Its specialty is in 3D printing osseointegrative biomedical materials.